Results for “ ”

Entry Author Date Location
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep 07/09/20 Philadelphia
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period 07/08/20 National
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy 07/02/20 San Diego
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing 07/02/20 San Francisco
Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration 07/01/20 San Francisco
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs 07/01/20 San Francisco
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder 06/30/20 San Francisco
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later 06/30/20 Boston
Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage 06/30/20 San Francisco
Roche Gets FDA OK for Injectable Version of Breast Cancer Drug 06/29/20 San Diego
FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues” 06/29/20 San Diego
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
New Xconomy Special Report: Biopharma and Tech Innovators Summer 2020 06/29/20 National
With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash 06/26/20 National
Eye Inflammation Dooms AbbVie Wet AMD Drug to an FDA Rejection 06/26/20 National
Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies 06/26/20 San Diego
Page 1 of 1969 next page »